Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Robotics manufacturer moving North American headquarters from Illinois to Wisconsin

As part of the expansion, Yaskawa will begin manufacturing robots in Franklin. The company purchased a more than 200,000-square-foot building in Franklin in 2023 for $20 million. The site was previously used by a packaging company.

The Wisconsin Economic Development Corp. is supporting the project with up to $18 million dollars in tax credits. Officials say the amount of credits awarded will be contingent upon hitting job creation and investment targets.

In a statement, Gov. Tony Evers said the expansion would bring millions of dollars of investment and hundreds of “high-quality” jobs to southeast Wisconsin.

Scientists Discover Anti-Aging Molecules Hiding in Your Blood

Three newly identified indole metabolites from a blood-dwelling bacterium were found to reduce skin cell inflammation and aging markers, offering promise for future anti-aging treatments. People spend a lot of time and money trying to keep their skin looking young, using everything from creams an

A single enzymatic switch steers cell fate in intestinal regeneration

Memorial Sloan Kettering Cancer Center researchers have identified a metabolic switch that determines whether intestinal stem cells become absorptive or secretory cells. Manipulating the enzyme OGDH either fuels cell expansion or redirects fate, with potential consequences for colitis recovery and regenerative therapy.

Stem cells in the intestine maintain a delicate balance between self-renewal and differentiation, continuously replenishing the epithelial lining of the gut.

As they divide, some daughter cells become absorptive enterocytes that expand the surface for , while others branch into that manufacture mucus, antimicrobial peptides, and hormones essential for gut immunity. Injury and inflammation can tip this balance, depleting secretory lineages and disrupting tissue integrity.

Nanogrid drug delivery systems developed for precise lung inflammation treatment

Understanding how drug delivery systems distribute in vivo remains a major challenge in developing nanomedicines. Especially in the lung, the complex and dynamic microenvironment often limits the effectiveness of existing approaches.

“Structural pharmaceutics” has been introduced as a new strategy to connect nanoparticle structures with physiological structures through advanced three-dimensional (3D) imaging and cross-scale characterizations.

In a study published in ACS Nano, a team led by Yin Xianzhen from the Lingang Laboratory and Zhang Jiwen from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences developed a precise targeting strategy for tracheal inflammation.